Patents by Inventor Christoph Brunner

Christoph Brunner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9728480
    Abstract: A passivation layer and a method of making a passivation layer are disclosed. In one embodiment the method for manufacturing a passivation layer includes depositing a first silicon based dielectric layer on a workpiece, the first silicon based dielectric layer comprising nitrogen, and depositing in-situ a second silicon based dielectric layer on the first silicon based dielectric layer, the second dielectric layer comprising oxygen.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: August 8, 2017
    Assignee: Infineon Technologies AG
    Inventors: Kurt Matoy, Hubert Maier, Christian Krenn, Elfriede Kraxner Wellenzohn, Helmut Schoenherr, Juergen Steinbrenner, Markus Kahn, Silvana Fister, Christoph Brunner, Herbert Gietler, Uwe Hoeckele
  • Publication number: 20150235917
    Abstract: A passivation layer and a method of making a passivation layer are disclosed. In one embodiment the method for manufacturing a passivation layer includes depositing a first silicon based dielectric layer on a workpiece, the first silicon based dielectric layer comprising nitrogen, and depositing in-situ a second silicon based dielectric layer on the first silicon based dielectric layer, the second dielectric layer comprising oxygen.
    Type: Application
    Filed: April 29, 2015
    Publication date: August 20, 2015
    Inventors: Kurt Matoy, Hubert Maier, Christian Krenn, Elfriede Kraxner Wellenzohn, Helmut Schoenherr, Juergen Steinbrenner, Markus Kahn, Silvana Fister, Christoph Brunner, Herbert Gietler, Uwe Hoeckele
  • Publication number: 20140117511
    Abstract: A passivation layer and a method of making a passivation layer are disclosed. In one embodiment the method for manufacturing a passivation layer includes depositing a first silicon based dielectric layer on a workpiece, the first silicon based dielectric layer comprising nitrogen, and depositing in-situ a second silicon based dielectric layer on the first silicon based dielectric layer, the second dielectric layer comprising oxygen.
    Type: Application
    Filed: October 30, 2012
    Publication date: May 1, 2014
    Applicant: Infineon Technologies AG
    Inventors: Kurt Matoy, Hubert Maier, Christian Krenn, Elfriede Kraxner Wellenzohn, Helmut Schoenherr, Juergen Steinbrenner, Markus Kahn, Fister Schlemitz Silvana, Christoph Brunner, Herbert Gietler, Uwe Hoeckele
  • Publication number: 20090325290
    Abstract: The present invention relates to polypeptide compositions which bind to cell surface epitopes and, in multivalent forms, cause or lead to the killing of cells including lymphoid tumor cells, and in the case of monovalent forms, cause immunosuppression or otherwise inhibit activation of lymphocytes. The invention further relates to nucleic acids encoding the polypeptides, methods for the production of the polypeptides, methods for killing cells, methods for immunosuppressing a patient, pharmaceutical, diagnostic and multivalent compositions and kits comprising the polypeptides and uses of the polypeptides.
    Type: Application
    Filed: April 20, 2009
    Publication date: December 31, 2009
    Inventors: Zoltan Nagy, Christoph Brunner, Michael Tesar, Elisabeth Thomassen Wolf, Robert Rauchenberger
  • Patent number: 7521047
    Abstract: The present invention relates to polypeptide compositions which bind to cell surface epitopes and, in multivalent forms, cause or lead to the killing of cells including lymphoid tumor cells, and in the case of monovalent forms, cause immunosuppression or otherwise inhibit activation of lymphocytes. The invention further relates to nucleic acids encoding the polypeptides, methods for the production of the polypeptides, methods for killing cells, methods for immunosuppressing a patient, pharmaceutical, diagnostic and multivalent compositions and kits comprising the polypeptides and uses of the polypeptides.
    Type: Grant
    Filed: November 15, 2001
    Date of Patent: April 21, 2009
    Assignees: GPC Biotech AG, Morphosys AG
    Inventors: Zoltan Nagy, Christoph Brunner, Michael Tesar, Elisabeth Thomassen-Wolf, Robert Rauchenberger
  • Publication number: 20080063699
    Abstract: The present invention relates to the use of pharmaceutical preparations comprising paclitaxel for administration to a human patient in need thereof.
    Type: Application
    Filed: October 15, 2004
    Publication date: March 13, 2008
    Inventors: Michael Teifel, Uwe Michaelis, Birgitta Sauer, Kerstin Bartelheim, Christoph Brunner, Kurt Naujoks
  • Publication number: 20030032782
    Abstract: The present invention relates to polypeptide compositions which bind to cell surface epitopes and, in multivalent forms, cause or lead to the killing of cells including lymphoid tumor cells, and in the case of monovalent forms, cause immunosuppression or otherwise inhibit activation of lymphocytes. The invention further relates to nucleic acids encoding the polypeptides, methods for the production of the polypeptides, methods for killing cells, methods for immunosuppressing a patient, pharmaceutical, diagnostic and multivalent compositions and kits comprising the polypeptides and uses of the polypeptides.
    Type: Application
    Filed: November 15, 2001
    Publication date: February 13, 2003
    Inventors: Zoltan Nagy, Christoph Brunner, Michael Tesar, Elisabeth Thomassen Wolf